Amy Rudolph, PhD, Joins Thryv Therapeutics' Board of Directors to Support Portfolio Progression into Heart Failure [Yahoo! Finance]
Thryv Holdings, Inc. (THRY)
Company Research
Source: Yahoo! Finance
inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, cardiometabolic diseases, and cardiomyopathies, today announced the appointment of Amy Rudolph, PhD, to its Board of Directors. Dr. Rudolph brings more than 25 years of leadership experience in the global pharmaceutical industry, with deep expertise spanning discovery, clinical development, medical affairs, and market access. Thryv Therapeutics Inc. Logo (CNW Group/Thryv Therapeutics Inc.) Dr. Rudolph currently serves as Head of Global Medical Affairs and Cross-TA Medical Affairs at Boehringer Ingelheim, where she leads a global transformation to build a market-leading Medical Affairs organization focused on external engagement, digital/AI integration, evidence generation, advanced analytics, and learning. "We are thrilled to welcome Amy Rudolph to our Board of Directors," said Paul Truex, Chairman and CEO of Thryv Therapeutics. "Her extensive experience in medical affairs, evidence generation, and cross-fun
Show less
Read more
Impact Snapshot
Event Time:
THRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
THRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
THRY alerts
High impacting Thryv Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
THRY
News
- Thryv to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26Business Wire
- Cautious Optimism for 2026, but Uncertainty is High Among Small Businesses According to New Thryv Data [Yahoo! Finance]Yahoo! Finance
- Cautious Optimism for 2026, but Uncertainty is High Among Small Businesses According to New Thryv DataBusiness Wire
- What Recent Developments Mean For The Changing Thryv Holdings THRY Investment Story [Yahoo! Finance]Yahoo! Finance
- Laughing Water Capital Sold Its Stake in Thryv Holdings (THRY) [Yahoo! Finance]Yahoo! Finance
THRY
Earnings
- 10/30/25 - Miss
THRY
Sec Filings
- 1/28/26 - Form SCHEDULE
- 1/9/26 - Form 8-K
- 1/8/26 - Form SCHEDULE
- THRY's page on the SEC website